investorscraft@gmail.com

Investing in Heartseed, Inc. (219A.T)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)9391.12301
Graham-Dodd Method115.03-95
Graham Formula0.00-100

Company description

Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan.
HomeMenuAccount